📝 Archean Chemical Industries Limited — results explained
Quarter ended June 2026 (Q1 FY27)
Archean Chemical Industries Limited reported revenue of ₹316 crore for the quarter ended June 2026 (Q1 FY27), up 8.4% from ₹291 crore in the same quarter last year, and up 8.2% sequentially over the March 2026 quarter.
Net profit fell 21.8% year-on-year to ₹41 crore, from ₹52 crore. Earnings per share (EPS) came in at ₹3.28.
Operating profit stood at ₹68 crore — an operating margin (OPM) of 21.4%, compared with 28.5% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Archean Chemical Industries Limited posted revenue of ₹1,065 crore, a growth of 5.1% over FY25, with a net profit of ₹154 crore (down 16.4% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,090 crore with a net profit of ₹143 crore.
Valuation snapshot
At the current price of ₹478.60, ACI has a market capitalisation of ₹5,909 crore and a trailing P/E of about 41.3.
Within the Chemicals industry, it is the 14th-largest of the 79 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 53.43%, foreign institutional investors (FIIs) 11.00%, domestic institutional investors (DIIs) 24.18%, public shareholders 11.39% of Archean Chemical Industries Limited.